David Russler-Germain

Medicine & Life Sciences

1. Acute Myeloid Leukemia 68%
2. Acute Promyelocytic Leukemia 22%
3. B-Cell Lymphoma 37%
4. B-Lymphocytes 18%
5. Cell Communication 16%
6. Cell Differentiation 17%
7. Cell Polarity 22%
8. Cell Transplantation 48%
9. Cell- and Tissue-Based Therapy 18%
10. Chimeric Antigen Receptors 28%
11. CpG Islands 21%
12. Cyclophosphamide 16%
13. Demethylation 21%
14. Direction compound 13%
15. DNA methyltransferase 3A 59%
16. Drug Therapy 13%
17. Electron Microscope Tomography 26%
18. Fats 13%
19. Ferritins 18%
20. fludarabine 25%
21. Follicular Lymphoma 22%
22. Gene Fusion 13%
23. Haploinsufficiency 23%
24. Head and Neck Neoplasms 18%
25. Hematopoietic Stem Cells 11%
26. Histones 16%
27. Immunoconjugates 27%
28. Immunotherapy 23%
29. Iron 14%
30. Leukemia 20%
31. Lymphoma 18%
32. Lymphoma, Large B-Cell, Diffuse 26%
33. Melanoma 14%
34. Melphalan 21%
35. Memory 65%
36. Methylation 22%
37. Methyltransferases 33%
38. Microtubules 17%
39. Mutation 48%
40. Myeloid Cells 30%
41. Natural Killer Cells 100%
42. Neoplasms 28%
43. Non-Hodgkin's Lymphoma 16%
44. Patient Transfer 21%
45. Pediatrics 11%
46. polatuzumab vedotin 46%
47. Squamous Cell Carcinoma of Head and Neck 20%
48. T-Lymphocytes 14%
49. Tissue Donors 33%
50. Transplants 22%